Ultrastructure and histomorphometric analysis of human umbilical cord vessels in preeclampsia: a potential role of VEGF, VEGFR-1 and VEGFR-2

被引:0
|
作者
Almasry, Shaima M. [1 ,2 ]
Elfayomy, Amr K. [3 ,4 ]
Hashem, Hala E. [5 ]
机构
[1] Taibah Univ, Dept Anat, Al Madinah Al Munawarah, Saudi Arabia
[2] Almansoura Univ, Dept Anat & Embryol, Mansoura, Egypt
[3] Taibah Univ, Dept Obstet & Gynecol, Al Madinah Al Munawarah, Saudi Arabia
[4] Zagazig Univ, Dept Obstet & Gynecol, Zagazig, Egypt
[5] Zagazig Univ, Dept Histol & Cell Biol, Zagazig, Egypt
关键词
VEGF; VEGFR-1; VEGFR-2; umbilical cord vessels; ENDOTHELIAL GROWTH-FACTOR; MUSCLE-CELL PROLIFERATION; FACTOR RECEPTOR-1; VASCULAR-PERMEABILITY; EXPRESSION; ARTERIAL; HYPOXIA; MOUSE;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim: This study aimed to analyze the ultrastructure and histomorphometric changes of the human umbilical cord vessels of preeclampsia compared to healthy pregnancies and the possible role of vascular endothelial growth factor (VEGF) and its receptors. Materials and Methods: Umbilical cord (UC) specimens were collected between August, 2014 and July, 2015. Histomorphometric analysis of UC vessels was performed utilizing an image analysis system. Cellular localization of VEGF, VEGFR-1 (VEGF receptor-1) and VEGFR-2 (VEGF receptor-2) were examined in immunohistochemically-stained sections of UC from 45 pregnancies with preeclampsia (PE) and 40 healthy pregnancies. Results: Compared with healthy pregnancies, UC venous measurements were significantly higher in PE; total venous area (p<0.001), lumina] venous area (p<0.001) and luminal venous index (p=0.005). Arterial measurements except for the total arterial area were significantly lower in the PE compared to healthy pregnancies, luminal arterial area (p=0.32) and luminal arterial index (p=0.004). Histological and ultrastructural examination of UC from PE revealed discontinuity of vascular endothelium and disorganized edematous widely spaced smooth muscle cells. We demonstrated a significant increase in tissue expression of VEGF in PE (16.6 +/- 0.1) compared to healthy pregnancies (12 +/- 0.8) (p=0.001). Also, significant higher VEGFR-1 expression in PE (20.5 +/- 2.5) compared to healthy pregnancies (9.5 +/- 1.2) (p<0.001) has been observed. However, tissue expression of VEGFR-2 was decreased significantly in PE (10.5 +/- 0.7) compared to healthy pregnancies (13.8 +/- 1.6) (p=0.043). Conclusions: Altered tissue expression of VEGF and its receptors in the UC vessels could play a crucial role in disturbing the UC vascular endothelium, smooth muscles and measurements and this may underlie the existence of preeclampsia.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 50 条
  • [21] Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1
    Zhang, Junxia
    Zhao, Peng
    Fu, Zhen
    Chen, Xiaolei
    Liu, Ning
    Lu, Ailin
    Li, Rui
    Shi, Lei
    Pu, Peiyu
    Kang, Chunsheng
    You, Yongping
    ONCOLOGY REPORTS, 2008, 20 (06) : 1457 - 1463
  • [22] The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer
    D'Haene, Nicky
    Koopmansch, Caroline
    Van Eycke, Yves-Remi
    Hulet, Francoise
    Allard, Justine
    Bouri, Sarah
    Rorive, Sandrine
    Remmelink, Myriam
    Decaestecker, Christine
    Maris, Calliope
    Salmon, Isabelle
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [23] Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer
    Yang, Feng
    Jin, Chen
    Jiang, Yong-jian
    Li, Ji
    Di, Yang
    Fu, De-Liang
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 541 - 549
  • [24] VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas
    Pisacane, AM
    Risio, M
    MELANOMA RESEARCH, 2005, 15 (01) : 39 - 43
  • [25] Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion
    Babiak, A
    Schumm, AM
    Wangler, C
    Loukas, M
    Wu, JB
    Dombrowski, S
    Matuschek, C
    Kotzerke, J
    Dehio, C
    Waltenberger, J
    CARDIOVASCULAR RESEARCH, 2004, 61 (04) : 789 - 795
  • [26] Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment
    Lee, Yoon-Jin
    Karl, Daniel L.
    Maduekwe, Ugwuji N.
    Rothrock, Courtney
    Ryeom, Sandra
    D'Amore, Patricia A.
    Yoon, Sam S.
    CANCER RESEARCH, 2010, 70 (21) : 8357 - 8367
  • [27] 老年大鼠心肌缺血后心脏VEGFR-1和VEGFR-2表达的研究
    黄晨
    张春蕾
    李源
    孟华
    中国老年学杂志, 2007, (02) : 113 - 115
  • [28] VEGFR-1,VEGFR-2 mRNA在局灶性脑缺血的表达及作用研究
    宫萍
    刘亢丁
    吴江
    中国老年学杂志, 2002, (05) : 402 - 403
  • [29] Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab
    Vihinen, Pia P.
    Ramadan, Susan
    Vuoristo, Meri-Sisko
    Hernberg, Micaela
    Tyynela-Korhonen, Kristiina
    Skytta, Tanja
    Koskivuo, Ilkka
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Syrjanen, Kari
    Pyrhonen, Seppo
    MELANOMA RESEARCH, 2011, 21 (05) : 431 - 437
  • [30] Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
    Moe, Kjartan
    Heidecke, Harald
    Dechend, Ralf
    Staff, Anne Cathrine
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2017, 10 : 83 - 89